The Effect of Imatinib Mesylate for Newly Diagnosed Philadelphia Chromosome-Positive, Chronic-Phase Myeloid Leukemia in Sub-Saharan African Patients: The Experience of Côte d'Ivoire

Table 3

Hematologic and cytogenetic response.

Characteristics	𝑛.(%)(𝑛=42)
Hematologic remission
Complete	32 (76)
Partial	10 (24)
Cytogenetic response	33 (79)
Major (Ph ≤ 35%)	19 (45)
Complete (Ph+ = 0%)	7 (17)
Partial (Ph+ = 1%–35%)	12 (28)
Minor (Ph+ 36% –95%)	14 (33)
Minimal/no (Ph+ >95%)	12 (29)